Answers are grounded in this paper and cite their sources.
Purpose Stage III non–small cell lung cancer (NSCLC) is a heterogeneous disease with no single definitive therapeutic approach. The role of neoadjuvant tyrosine kinase inhibitors in stage III ALK-positive NSCLC remains unknown. The ALNEO study evaluated the activity and safety of perioperative alectinib in this population. Patients and Methods ALNEO is an open-label, single-arm, multicenter phase II study enrolling treatment-naïve patients with potentially resectable stage III ALK-positive NSCLC. Patients received neoadjuvant alectinib 600 mg twice daily for 8 weeks, followed by surgery and adjuvant alectinib for up to 96 weeks. The primary end point was major pathologic response (MPR; ≤10% residual viable tumor cells) assessed by blinded independent central review. Secondary end points included pathologic complete response (pCR), objective response rate (ORR), event-free survival (EFS), disease-free survival (DFS), overall survival (OS), and safety. Results From May 2021 to July 2024, 33 patients were enrolled. The median age was 62 years (range, 33-79), 70% were female, and 52% were never smokers. Clinical stage was IIIA in 64% and IIIB in 36%. All patients completed neoadjuvant treatment, and 28 (85%) underwent surgery, most commonly lobectomy (75%). R0 resection was achieved in 24 (86%). MPR was observed in 14 patients (42%; 95% CI, 26 to 61), including four pCRs (12%; 95% CI, 3 to 28). ORR was 67%. Adjuvant treatment was initiated in 26 (79%) patients. After a median follow-up of 26.8 months, median EFS, DFS, and OS were not reached; six patients (18%) experienced disease recurrence. Grade ≥3 adverse events occurred in 9% and 27% of patients during neoadjuvant and adjuvant treatment, respectively. Conclusion The ALNEO study met its primary end point, suggesting perioperative alectinib as a feasible and active approach in potentially resectable stage III ALK-positive NSCLC.
No takes yet. Share an insight, caveat, or question.
Leonetti et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: